The same drugs that transformed obesity treatment are now being investigated for substance use disorders, fueling interest in ...
Share on Pinterest New research suggests that GLP-1 drugs like Ozempic may help curb alcohol use. Image credit: Stefania Pelfini, La Waziya Photography/Getty Images. Alcohol use disorder is a ...
(NEW YORK) — Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit — it could help people drink less alcohol. A study published in JAMA Psychiatry ...
The first published evidence from humans that semaglutide specifically reduces the symptoms of alcohol use disorder (AUD) has been published in The Journal of Clinical Psychiatry and details a recent ...
Peptides have gone mainstream, and with them a predictable question: can you drink on them? The theme is not reassuring: in ...
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new research led by Christian ...
A man prescribed semaglutide for obesity saw his drinking fall dramatically over 10 months, adding fresh real-world evidence to the idea that GLP-1 drugs may help curb alcohol cravings while ...
People with alcohol use disorder who took semaglutide, also known as Wegovy, drank less and had fewer cravings for alcohol, new research found. Reading time 3 minutes A study out this week suggests ...
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential for novel treatments pending further clinical ...
Share on Pinterest Semaglutide drugs were tied to a significantly lower incidence of alcohol use disorder in a new study. Image credit: JNemchinova/Getty Images. A new study from Case Western Reserve ...
A new study by researchers at the Case Western Reserve University School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and ...